Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
A Novel Functional Variant in the Stem Cell Growth Factor (SCGF) Promoter (-539C/T) Protects Against Severe Malarial Anemia
Infection and Immunity, 11/05/09
Ouma C et al. – Results presented here demonstrate that homozygous T at –539 in the SCGF promoter is associated with elevated SCGF production, enhanced erythropoiesis, and protection against the development of SMA in children with falciparum malaria.
Related Articles
Malaria in patients with sickle cell anemia: burden, risk factors and outcome at outpatient clinic and during hospitalization
Blood, 11/18/09
Relevance Score: 67%
Erythropoiesis Stimulating Agents in Heart Failure Patients with Anemia: A Meta-Analysis
Cardiovascular Drugs and Therapy, 11/03/09
Relevance Score: 66%
New advances in the treatment of acquired severe aplastic anaemia
International Journal of Hematology, 10/07/09
Relevance Score: 66%
Severe iron overload in Blackfan-Diamond anemia: A case-control study
American Journal of Hematology, 10/09/09
Relevance Score: 65%
Immunosuppressive Therapy as Frontline Treatment for 33 Children with Acquired Severe Aplastic Anemia
Pediatric Hematology and Oncology, 10/02/09
Relevance Score: 65%
Today in Tropical/Parasitology...keeping you current
Receive free subspecialty "5-minute updates" via email
Heroes or villains? T regulatory cells in malaria infection
Trends in Parasitology, 11/25/09
Access to malaria treatment in young children of rural Burkina Faso
Malaria Journal, 11/25/09
Fascioliasis: can Cuba conquer this emerging parasitosis
Trends in Parasitology, 11/25/09
Article Search
Sponsor


See Latest Articles


